Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

APOE4 increases energy metabolism in APOE-isogenic iPSC-derived neurons

View through CrossRef
AbstractThe apolipoprotein E4 (APOE4) allele represents the major genetic risk factor for Alzheimer’s disease (AD). In contrast, APOE2 is known to lower the AD risk while APOE3 is defined as risk neutral. APOE plays a prominent role in the bioenergetic homeostasis of the brain, and early-stage metabolic changes have been detected in brains of AD patients. Although APOE is primarily expressed by astrocytes in the brain, neurons also have been shown as source for APOE. However, little is known about the differential role of the three APOE isoforms for neuronal energy homeostasis. In this study, we generated pure human neurons (iN cells) from APOE-isogenic induced pluripotent stem cells (iPSCs), expressing either APOE2, APOE3, APOE4 or carrying an APOE-knockout (KO) to investigate APOE isoform-specific effects on neuronal energy metabolism. We showed that endogenously produced APOE4 enhanced mitochondrial ATP production in APOE-isogenic iN cells but not in the corresponding iPS cell line. This effect neither correlated with the expression levels of mitochondrial fission or fusion proteins, nor with the intracellular or secreted levels of APOE, which were similar for APOE2, APOE3 and APOE4 iN cells. ATP production and basal respiration in APOE-KO iN cells strongly differed from APOE4 and more closely resembled APOE2 and APOE3 iN cells indicating a gain-of-function mechanism of APOE4 rather than a loss-of-function. Taken together, our findings in APOE isogenic iN cells reveal an APOE genotype-dependent and neuron-specific regulation of oxidative energy metabolism.
Title: APOE4 increases energy metabolism in APOE-isogenic iPSC-derived neurons
Description:
AbstractThe apolipoprotein E4 (APOE4) allele represents the major genetic risk factor for Alzheimer’s disease (AD).
In contrast, APOE2 is known to lower the AD risk while APOE3 is defined as risk neutral.
APOE plays a prominent role in the bioenergetic homeostasis of the brain, and early-stage metabolic changes have been detected in brains of AD patients.
Although APOE is primarily expressed by astrocytes in the brain, neurons also have been shown as source for APOE.
However, little is known about the differential role of the three APOE isoforms for neuronal energy homeostasis.
In this study, we generated pure human neurons (iN cells) from APOE-isogenic induced pluripotent stem cells (iPSCs), expressing either APOE2, APOE3, APOE4 or carrying an APOE-knockout (KO) to investigate APOE isoform-specific effects on neuronal energy metabolism.
We showed that endogenously produced APOE4 enhanced mitochondrial ATP production in APOE-isogenic iN cells but not in the corresponding iPS cell line.
This effect neither correlated with the expression levels of mitochondrial fission or fusion proteins, nor with the intracellular or secreted levels of APOE, which were similar for APOE2, APOE3 and APOE4 iN cells.
ATP production and basal respiration in APOE-KO iN cells strongly differed from APOE4 and more closely resembled APOE2 and APOE3 iN cells indicating a gain-of-function mechanism of APOE4 rather than a loss-of-function.
Taken together, our findings in APOE isogenic iN cells reveal an APOE genotype-dependent and neuron-specific regulation of oxidative energy metabolism.

Related Results

Lipoprotein glomerulopathy induced by ApoE Kyoto mutation in ApoE-deficient mice
Lipoprotein glomerulopathy induced by ApoE Kyoto mutation in ApoE-deficient mice
Abstract Background: Lipoprotein glomerulopathy (LPG) is a rare autosomal dominant kidney disease that is most commonly caused by mutations in ApoE Kyoto (p.R43C) and ApoE ...
The Contributions of the Endolysosomal Compartment and Autophagy to APOE ɛ4 Allele-Mediated Increase in Alzheimer’s Disease Risk
The Contributions of the Endolysosomal Compartment and Autophagy to APOE ɛ4 Allele-Mediated Increase in Alzheimer’s Disease Risk
Apolipoprotein E4 (APOE4), although yet-to-be fully understood, increases the risk and lowers the age of onset of Alzheimer’s disease (AD), which is the major cause of dementia amo...
The role of ApoE on fatty acid transport from neurons to astrocytes under ischemia/hypoxia conditions
The role of ApoE on fatty acid transport from neurons to astrocytes under ischemia/hypoxia conditions
Abstract Background The aim of this study was to investigate whether ischemia/hypoxia conditions induce fatty acid transport from neurons to astrocytes and whether this me...
Neuronal ApoE4 in Alzheimer’s disease and potential therapeutic targets
Neuronal ApoE4 in Alzheimer’s disease and potential therapeutic targets
The most prevalent genetic risk factor for Alzheimer’s disease (AD) is Apolipoprotein E (ApoE), a gene located on chromosome 19 that encodes three alleles (e2, e3, and e4) that giv...
Astrocyte-secreted glypican-4 drives APOE4-dependent tau pathology
Astrocyte-secreted glypican-4 drives APOE4-dependent tau pathology
ABSTRACTThe aggregation of tau proteins into insoluble filaments and the spread of these filaments across brain regions are the major drivers of neurodegeneration in tauopathies, i...
APOE‐targeted epigenome therapy for late onset Alzheimer’s disease
APOE‐targeted epigenome therapy for late onset Alzheimer’s disease
AbstractBackgroundCarrying the APOEe4 variant significantly increases lifetime risk for LOAD. The accumulating evidence suggest that alteration of the expression of APOEe4 and APOE...

Back to Top